nach oben

29.02.2024 | Mini-Review

Monogenic diabetes

verfasst von: Yukio Horikawa, Kazuyoshi Hosomichi, Daisuke Yabe

Erschienen in: Diabetology International

Einloggen, um Zugang zu erhalten

Abstract

Diseases in which genetic factors contribute to nearly 100% of the causation by single-gene mutations are referred to as monogenic disorders or Mendelian genetic diseases. These include neonatal diabetes mellitus (NDM), presenting within the first six months of life, maturity-onset diabetes of the young (MODY), developing later in childhood or adolescence, mitochondrial diabetes (MIDD), and insulin-resistant disorders, etc. On the other hand, common lifestyle-related diseases such as type 2 diabetes (T2DM), hypertension and dyslipidemia are multifactorial, emerging through complex interplay of genetic and environmental factors. The identification of causative genes for diabetes resulting from single-gene abnormalities not only unveils previously unknown mechanisms of insulin secretion and sensitivity at the molecular level but also reveals novel targets for drug development. Moreover, monogenic diabetes in which insulin secretion is impaired serve to clarify the pathophysiology and suggest therapeutic targets for the common multifactorial type 2 diabetes mellitus prevalent in the Japanese population, which is characterized by impaired insulin secretion. In this study, we characterize the various monogenic subtypes of diabetes so far identified.

Hashimoto Y, Dateki S, Hirose M, et al. Molecular and clinical features of KATP -channel neonatal diabetes mellitus in Japan. Pediatr Diabetes. 2017;18:532–9.CrossRefPubMed

Horikawa Y. Maturity-onset diabetes of the young (MODY) as a model for elucidating the multifactorial origin of type 2 diabetes mellitus. J Diabetes Investig. 2018;9:704–12.CrossRefPubMedPubMedCentral

Chakera AJ, Steele AM, Gloyn AL, et al. Recognition and management of individuals with hyperglycemia because of a heterozygous glucokinase mutation. Diabetes Care. 2015;38:1383–92.CrossRefPubMed

Hattersley AT, Beards F, Ballantyne E, et al. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet. 1998;19:268–70.CrossRefPubMed

Steele AM, Shields BM, Wensley KJ, et al. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia. JAMA. 2014;311:279–86.CrossRefPubMed

Cho J, Horikawa Y, Enya M, et al. L-Arginine prevents cereblon-mediated ubiquitination of glucokinase and stimulates glucose-6-phosphate production in pancreatic β-cells. Commun Biol. 2020;3:497.CrossRefPubMedPubMedCentral

Cho J, Horikawa Y, Oiwa Y, Hosomichi K, Yabe D, Imai T. Glucokinase Variant Proteins Are Resistant to Fasting-Induced Uridine Diphosphate Glucose-Dependent Degradation in Maturity-Onset Diabetes of the Young Type 2 Patients. Int J Mol Sci. 2023;24:15842.CrossRefPubMedPubMedCentral

Bellanne-Chantelot C, Levy DJ, Carette C, et al. Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene. J Clin Endocrinol Metab. 2011;96:E1346–51.CrossRefPubMed

Horikawa Y, Enya M, Fushimi N, Fushimi Y, Takeda J. Screening of diabetes of youth for hepatocyte nuclear factor 1 mutations: clinical phenotype of HNF1β-related maturity-onset diabetes of the young and HNF1α-related maturity-onset diabetes of the young in Japanese. Diabet Med. 2014;31:721–7.CrossRefPubMed

10.

Menzel R, Kaisaki PJ, Rjasanowski I, et al. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1-alpha (HNF-1-alpha)gene. Diabet Med. 1998;15:816–20.CrossRefPubMed

11.

McDonald TJ, Shields BM, Lawry J, et al. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes. Diabetes Care. 2011;34:1860–2.CrossRefPubMedPubMedCentral

12.

Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet. 2003;362:1275–81.CrossRefPubMed

13.

Bluteau O, Jeannot E, Bioulac-Sage P, et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet. 2002;32:312–5.CrossRefPubMed

14.

Izzi C, Dordoni C, Econimo L, et al. Variable Expressivity of HNF1B Nephropathy, From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease. Kidney Int Rep. 2020;5:2341–50.CrossRefPubMedPubMedCentral

15.

Dubois-Laforgue D, Cornu E, Saint-Martin C, et al. Associated clinical spectrum, long-term prognosis, and genotype/phenotype correlations in 201 adult patients with hepatocyte nuclear factor 1B (HNF1B) molecular defects. Diabetes Care. 2017;40:1436–43.CrossRefPubMed

16.

Bellanne-Chantelot C, Clauin S, Chauveau D, et al. Large genomic rearrangements in the hepatocyte nuclear factor-1-beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes. 2005;54:3126–32.CrossRefPubMed

17.

Cannon S, Clissold R, Sukcharoen K, et al. Recurrent 17q12 microduplications contribute to renal disease but not diabetes. J Med Genet. 2023;60:491–7.CrossRefPubMed

18.

Pearson ER, Boj SF, Steele AM, et al. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med. 2007;4:e118.CrossRefPubMedPubMedCentral

19.

Horikawa Y, Enya M, Mabe H, et al. NEUROD1-deficient diabetes (MODY6): Identification of the first cases in Japanese and the clinical features. Pediatr Diabetes. 2018;19:236–42.CrossRefPubMed

20.

Yoshiji S, HorikawaY KS, et al. First Japanese Family with PDX1-MODY (MODY4) A Novel PDX1 Frameshift Mutation, Clinical Characteristics, and Implications. J Endocr Soc. 2021;6:159.CrossRef

21.

Murphy R, Turnbull DM, Walker M, Hattersley AT. Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med. 2008;25:383–99.CrossRefPubMed

22.

Ben Harouch S, et al. INSR-Related Severe Syndromic Insulin Resistance. In: Seattle WA, editor., et al., GeneReviews® [Internet]. Seattle: University of Washington; 2018. p. 1993–2020.

23.

Hosoe J, Kadowaki H, Miya F, et al. Structural Basis and Genotype-Phenotype Correlations of INSR Mutations Causing Severe Insulin Resistance. Diabetes. 2017;66:2713–23.CrossRefPubMed

24.

Cook JR, Langlet F, Kido Y, Accili D. Pathogenesis of selective insulin resistance in isolated hepatocytes. J Biol Chem. 2015;290:13972–80.CrossRefPubMedPubMedCentral

25.

Xia Q, Grant SF. The genetics of human obesity. Ann N Y Acad Sci. 2013;1281:178–90.CrossRefPubMedPubMedCentralADS

26.

Garg A. Clinical review#: Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab. 2011;96:3313–25.CrossRefPubMedPubMedCentral

27.

Urano F. Wolfram Syndrome: Diagnosis, Management, and Treatment. Curr Diab Rep. 2016;16:6.CrossRefPubMedPubMedCentral

28.

Bea-Mascato B, Valverde D. Genotype-phenotype associations in Alström syndrome: a systematic review and meta-analysis. J Med Genet. 2023;61:18–26.CrossRefPubMed

29.

Mujahid S, Hunt KF, Cheah YS, et al. The Endocrine and Metabolic Characteristics of a Large Bardet-Biedl Syndrome Clinic Population. J Clin Endocrinol Metab. 2018;103:1834–41.CrossRefPubMed

30.

Burnett LC, LeDuc CA, Sulsona CR, et al. Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome. J Clin Invest. 2017;127:293–305.CrossRefPubMed

31.

Bacchetta R, Roncarolo MG. IPEX Syndrome from diagnosis to cure, learning along the way. J Allergy Clin Immunol. 2023;S0091–6749(23):01512–9.

32.

Yang Y, Chan L. Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes. Endocr Rev. 2016;37:190–222.CrossRefPubMedPubMedCentral

33.

Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.CrossRefPubMedPubMedCentral

34.

Horikawa Y, Hosomichi K, Enya M, et al. No novel, high penetrant gene might remain to be found in Japanese patients with unknown MODY. J Hum Genet. 2018;63:821–9.CrossRefPubMed

35.

Spracklen CN, Horikoshi M, Kim YJ, et al. Identification of type 2 diabetes loci in 433,540 East Asian individuals. Nature. 2020;582:240–5.CrossRefPubMedPubMedCentralADS

36.

Najmi LA, Aukrust I, Flannick J, et al. Functional investigations of HNF1A identify rare variants as risk factors for type 2 diabetes in the general population. Diabetes. 2017;66:335–46.CrossRefPubMed

37.

Bonnefond A, Boissel M, Bolze A, et al. Pathogenic variants in actionable MODY genes are associated with type 2 diabetes. Nat Metab. 2020;2:1126–34.CrossRefPubMed

Titel: Monogenic diabetes
verfasst von: Yukio Horikawa
Kazuyoshi Hosomichi
Daisuke Yabe
Publikationsdatum: 29.02.2024
Verlag: Springer Nature Singapore
Erschienen in: Diabetology International
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI: https://doi.org/10.1007/s13340-024-00698-6

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen